These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38409529)

  • 21. Validation and implementation of an algorithm for reporting the automated absolute neutrophil count from selected flagged specimens.
    Sireci AN; Herlitz L; Lee K; Bautista JL; Kratz A
    Am J Clin Pathol; 2010 Nov; 134(5):720-5. PubMed ID: 20959654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum pegfilgrastim concentrations during recovery of absolute neutrophil count in patients with cancer receiving pegfilgrastim after chemotherapy.
    Yang BB; Kido A; Shibata A
    Pharmacotherapy; 2007 Oct; 27(10):1387-93. PubMed ID: 17896894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials.
    Ludmir EB; Subbiah IM; Mainwaring W; Miller AB; Lin TA; Jethanandani A; Espinoza AF; Mandel JJ; Fang P; Smith BD; Smith GL; Pinnix CC; Sedrak MS; Kimmick GG; Stinchcombe TE; Jagsi R; Thomas CR; Fuller CD; VanderWalde NA
    J Geriatr Oncol; 2020 Apr; 11(3):451-454. PubMed ID: 31711757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Influence of Age on the Diagnostic Performance of White Blood Cell Count and Absolute Neutrophil Count in Suspected Pediatric Appendicitis.
    Bachur RG; Dayan PS; Dudley NC; Bajaj L; Stevenson MD; Macias CG; Mittal MK; Bennett J; Sinclair K; Monuteaux MC; Kharbanda AB
    Acad Emerg Med; 2016 Nov; 23(11):1235-1242. PubMed ID: 27251399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.
    Goswami ND; Tsalik EL; Naggie S; Miller WC; Horton JR; Pfeiffer CD; Hicks CB
    Trials; 2014 Jan; 15():31. PubMed ID: 24450313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute neutrophil count as a diagnostic guide for the use of MRI in the workup of suspected appendicitis in children.
    Corkum KS; Oyetunji TA; Grabowski JE; Rigsby CK; Lautz TB
    J Pediatr Surg; 2019 Jul; 54(7):1359-1364. PubMed ID: 30001891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absolute neutrophil count nadir in healthy pediatric patients with the Duffy-null phenotype.
    Merz LE; Li SH; Ney G; Michniacki TF; Hannibal MC; Walkovich KJ
    Blood Adv; 2023 Aug; 7(15):4182-4185. PubMed ID: 37285802
    [No Abstract]   [Full Text] [Related]  

  • 28. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group.
    Spira AI; Stewart MD; Jones S; Chang E; Fielding A; Richie N; Wood LS; Thompson MA; Jones L; Nair A; Mahal BA; Gerber DE
    Clin Cancer Res; 2021 May; 27(9):2416-2423. PubMed ID: 33563636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synovial Fluid Absolute Neutrophil Count and Neutrophil-To-Lymphocyte Ratio are not Superior to Polymorphonuclear Percentage in Detecting Periprosthetic Joint Infection.
    Dilley JE; Seetharam A; Meneghini RM; Kheir MM
    J Arthroplasty; 2023 Jan; 38(1):146-151. PubMed ID: 35843381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of Symptom Duration and C-Reactive Protein, White Blood Cell Count, and Absolute Neutrophil Count in the Evaluation of Pediatric Appendicitis.
    Davis J; Kasmire K
    J Emerg Med; 2021 Apr; 60(4):428-435. PubMed ID: 33353813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sponsorship of clinical trials related to the spine: Trends over time and comparative analysis of trial characteristics by sponsorship type.
    Caruana DL; Jiang W; Elaydi A; Grauer JN
    N Am Spine Soc J; 2024 Mar; 17():100296. PubMed ID: 38130466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sponsor on enrollment criteria in non-small cell lung cancer clinical trials.
    Cooper RA; Chai Y; Nieva J
    J Cancer Policy; 2022 Sep; 33():100336. PubMed ID: 35605888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between white blood cell count and neutrophil count after chemotherapy administration at a day hospital.
    Germa Lluch JR; Piulats RB
    Rev Esp Oncol; 1985; 32(4):627-32. PubMed ID: 3880158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study.
    Bakouny Z; Labaki C; Bhalla S; Schmidt AL; Steinharter JA; Cocco J; Tremblay DA; Awad MM; Kessler A; Haddad RI; Evans M; Busser F; Wotman M; Curran CR; Zimmerman BS; Bouchard G; Jun T; Nuzzo PV; Qin Q; Hirsch L; Feld J; Kelleher KM; Seidman D; Huang H; Anderson-Keightly HM; El Zarif T; Alaiwi SA; Champagne C; Rosenbloom TD; Stewart PS; Johnson BE; Trinh Q; Tolaney SM; Galsky MD; Choueiri TK; Doroshow DB
    Ann Oncol; 2022 Aug; 33(8):836-844. PubMed ID: 35715285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma.
    Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Kim JE; Kim CW; Huh J
    Am J Clin Pathol; 2012 Dec; 138(6):846-54. PubMed ID: 23161719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.
    Ni Y; Wright J; Perentesis J; Lingren T; Deleger L; Kaiser M; Kohane I; Solti I
    BMC Med Inform Decis Mak; 2015 Apr; 15():28. PubMed ID: 25881112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies.
    Cohen JW; Akshintala S; Kane E; Gnanapragasam H; Widemann BC; Steinberg SM; Shah NN
    Oncologist; 2020 Jun; 25(6):532-540. PubMed ID: 31943534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil Effector Functions Are Not Impaired in Duffy Antigen Receptor for Chemokines (DARC)-Null Black South Africans.
    Naidoo KK; Ngubane A; Gaza P; Moodley A; Ndung'u T; Thobakgale CF
    Front Immunol; 2019; 10():551. PubMed ID: 30972057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporating Absolute Phagocyte Count With Absolute Neutrophil Count as a Measure for Safe Discharge for Pediatric Oncology Febrile Neutropenia: A Pilot Study.
    Picca A; Wahlquist AE; Hudspeth M
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1000-e1002. PubMed ID: 33065712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World.
    Karim S; Xu Y; Kong S; Abdel-Rahman O; Quan ML; Cheung WY
    Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e160-e166. PubMed ID: 31133363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.